Drugs Approved for Myeloproliferative Neoplasms
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms. The list includes generic and brand names. This page also lists common drug combinations used in myeloproliferative neoplasms. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in myeloproliferative neoplasms that are not listed here.
Drugs Approved for Myeloproliferative Neoplasms
- Adriamycin PFS (Doxorubicin Hydrochloride)
- Adriamycin RDF (Doxorubicin Hydrochloride)
- Arsenic Trioxide
- Azacitidine
- Cerubidine (Daunorubicin Hydrochloride)
- Clafen (Cyclophosphamide)
- Cyclophosphamide
- Cytarabine
- Cytosar-U (Cytarabine)
- Cytoxan (Cyclophosphamide)
- Dacogen (Decitabine)
- Dasatinib
- Daunorubicin Hydrochloride
- Decitabine
- Doxorubicin Hydrochloride
- Gleevec (Imatinib Mesylate)
- Imatinib Mesylate
- Jakafi (Ruxolitinib Phosphate)
- Nilotinib
- Rubidomycin (Daunorubicin Hydrochloride)
- Ruxolitinib Phosphate
- Sprycel (Dasatinib)
- Tarabine PFS (Cytarabine)
- Tasigna (Nilotinib)
- Trisenox (Arsenic Trioxide)
- Vidaza (Azacitidine)
.png)
No hay comentarios:
Publicar un comentario